23:39 , Oct 21, 2013 |  BC Extra  |  Politics & Policy

FDA awards over $14M in grants for rare diseases

FDA awarded more than $14 million under its Orphan Products Grants Program to 15 projects focused on developing drugs and devices for rare diseases from two companies and 13 universities. The awards include $167,000 for...
07:00 , May 28, 2012 |  BC Week In Review  |  Company News

Alkeus board of directors update

Alkeus Pharmaceuticals Inc., Boston, Mass.   Business: Ophthalmic   Appointed: Joshua Boger, former CEO of Vertex Pharmaceuticals Inc., as executive chairman   ...
01:19 , May 24, 2012 |  BC Extra  |  Company News

Vertex's Boger joins eye company Alkeus

Alkeus Pharmaceuticals Inc. (Boston, Mass.) appointed Joshua Boger as executive chairman. Boger is the founder of Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), where he served as CEO until his retirement in May 2009. Boger remains a member...